Clinical Manual for Management of the HIV-Infected ... - myCME.com
Clinical Manual for Management of the HIV-Infected ... - myCME.com
Clinical Manual for Management of the HIV-Infected ... - myCME.com
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>for</strong> treatment is appropriate, and be knowledgeable<br />
about referral resources and mechanisms. If <strong>the</strong> patient<br />
is using injection drugs, emphasize <strong>the</strong> fact that <strong>HIV</strong><br />
is readily transmitted by sharing needles and o<strong>the</strong>r<br />
injection equipment and that reusing or sharing<br />
needles and syringes can cause additional infections (eg,<br />
endocarditis, hepatitis C). Assess <strong>the</strong> patient’s readiness<br />
to change his or her drug injection practices, and refer<br />
to drug treatment programs as appropriate. Refer to<br />
an addiction counselor <strong>for</strong> motivational interviewing<br />
or o<strong>the</strong>r interventions, if available. After <strong>com</strong>pletion<br />
<strong>of</strong> substance abuse treatment, relapse prevention<br />
programs and ongoing support will be needed. If <strong>the</strong><br />
patient continues to use needles, discuss safer needleuse<br />
practices (Table 3) and refer to a needle exchange<br />
program, if one is available, so that syringes and needles<br />
are not reused. A partial listing <strong>of</strong> needle exchange sites<br />
may be found at: http://www.nasen.org, although many<br />
states ei<strong>the</strong>r do not have or cannot list <strong>the</strong>ir facilities.<br />
Local harm-reduction activists may be aware <strong>of</strong> specific<br />
programs <strong>for</strong> obtaining clean needles and syringes.<br />
Patient-education flyers on safer injection practices,<br />
safer stimulant use, overdose prevention, and o<strong>the</strong>r<br />
topics are available on <strong>the</strong> Midwest AIDS Education<br />
and Training Center’s Web site at http://www.uic.edu/<br />
depts/matec/resource.html.<br />
Table 3. Needle-Use Practices to Reduce <strong>the</strong> Risk <strong>of</strong> <strong>HIV</strong><br />
Infection and Transmission<br />
•<br />
•<br />
•<br />
•<br />
•<br />
•<br />
•<br />
Never reuse or share needles, syringes, water, or drug preparation<br />
equipment. If <strong>the</strong>re is a need to reuse syringe equipment, it should<br />
be cleaned properly with bleach or water, with care taken not to<br />
share <strong>the</strong> materials (eg, container, water) used <strong>for</strong> cleaning.<br />
It is best to use only sterile syringes obtained from a reliable source<br />
(pharmacy, needle exchange program). In addition, reusing one’s<br />
own syringes can lead to various bacterial infections, abscesses, etc.<br />
Use sterile or boiled water to prepare drugs. If unavailable, use clean<br />
water from a reliable source, such as fresh tap water.<br />
Use a new or disinfected container (cooker) and a new filter (cotton)<br />
to prepare drugs. Cooking <strong>the</strong> drugs be<strong>for</strong>e injecting can reduce <strong>the</strong><br />
chances <strong>of</strong> transmitting <strong>HIV</strong> when sharing equipment.<br />
Clean <strong>the</strong> skin around <strong>the</strong> injection site with a new alcohol swab<br />
be<strong>for</strong>e injecting, and use a sterile or clean cotton pad to stop <strong>the</strong><br />
blood flow after injecting. Also, using a tourniquet when injecting<br />
can help reduce damage to veins and assist <strong>the</strong> user in controlling<br />
<strong>the</strong> shot and avoiding overdose.<br />
Safely dispose <strong>of</strong> syringes after one use, ei<strong>the</strong>r in a specially made<br />
sharps container, or a clean detergent container. Many pharmacies<br />
<strong>of</strong>fer disposal programs <strong>for</strong> used syringes.<br />
For patient flyers on safer injection practices, safer stimulant use,<br />
overdose prevention, and o<strong>the</strong>r topics, go to http://www.uic.edu/<br />
depts/matec/resource.html.<br />
Section 2—Health Maintenance and Disease Prevention | 2–27<br />
Noninjection Drug Use and Prevention <strong>of</strong> <strong>HIV</strong><br />
Transmission<br />
Exposure to <strong>HIV</strong> through contaminated blood may<br />
also occur during noninjection drug use; <strong>for</strong> example, by<br />
sharing cocaine straws or sniffers through which cocaine<br />
is inhaled. These straws can easily penetrate fragile nasal<br />
mucosa and be<strong>com</strong>e contaminated with blood from one<br />
user be<strong>for</strong>e being used by ano<strong>the</strong>r individual, who may<br />
<strong>the</strong>n experience mucous membrane exposure or even a<br />
cut or break in <strong>the</strong> mucous membrane from <strong>the</strong> bloody<br />
object. Straws or sniffers should not be shared.<br />
Tattoo, Piercing, and Acupuncture Equipment<br />
Patients should be aware <strong>of</strong> <strong>the</strong> risk <strong>of</strong> contamination<br />
<strong>of</strong> tattoo equipment, inks, and piercing equipment, and<br />
avoid situations where <strong>the</strong>y might ei<strong>the</strong>r transmit <strong>HIV</strong><br />
or pick up o<strong>the</strong>r bloodborne pathogens.<br />
Acupuncturists generally use sterile needles, but clients<br />
should verify this be<strong>for</strong>e using <strong>the</strong>ir services.<br />
Maternal-Infant <strong>HIV</strong> Transmission<br />
<strong>HIV</strong>-positive women can have healthy pregnancies,<br />
with good health out<strong>com</strong>es <strong>for</strong> both mo<strong>the</strong>r and baby.<br />
For this to occur, women must know <strong>the</strong>ir <strong>HIV</strong> status as<br />
early as possible, preferably be<strong>for</strong>e be<strong>com</strong>ing pregnant.<br />
Although intervention to reduce <strong>the</strong> risk <strong>of</strong> perinatal<br />
infection is most effective if begun early in pregnancy,<br />
or preferably be<strong>for</strong>e pregnancy, it may be beneficial at<br />
any point in <strong>the</strong> pregnancy, even as late as during labor.<br />
For fur<strong>the</strong>r in<strong>for</strong>mation, see chapter Reducing Maternal-<br />
Infant <strong>HIV</strong> Transmission.<br />
Postexposure Prophylaxis <strong>for</strong> Nonoccupational <strong>HIV</strong><br />
Exposure<br />
Postexposure prophylaxis (PEP) may be considered<br />
<strong>for</strong> certain sexual exposures, sexual assaults, and<br />
o<strong>the</strong>r nonoccupational exposures to <strong>HIV</strong>. As with<br />
occupational PEP, a risk assessment must be <strong>com</strong>pleted<br />
and antiretroviral <strong>the</strong>rapy, if indicated, must be<br />
started in a timely manner. The risks and toxicities <strong>of</strong><br />
antiretroviral drugs must be weighed against potential<br />
benefits, and <strong>the</strong> client’s in<strong>for</strong>med consent must<br />
be obtained. For fur<strong>the</strong>r in<strong>for</strong>mation, see chapter<br />
Nonoccupational Postexposure Prophylaxis.